LOS ANGELES (KABC) -- Many people taking a popular diabetes medication have been experiencing weight loss as one of the side effects. Low blood sugar levels brought 59-year-old Anda Lam to her ...

Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and reduce the risk of cardiovascular problems. Both drugs come as an injection. Ozempic is not ...

Both Victoza and Ozempic can help reduce the risk of heart attack and stroke in people with type 2 diabetes. Victoza is ...

Victoza (liraglutide) is a prescription drug used to treat type 2 diabetes and lower the risk of cardiovascular problems in certain people. Mild side effects of the drug include nausea, diarrhea, and ...

Novo Nordisk launched a consumer campaign for Victoza, emphasizing the product’s ability to bring down blood sugar levels and body weight in patients with type 2 diabetes. The campaign features print ...

Branded content furnished by our promotional partners. The Daily Sundial editorial staff is not involved in its production. Content does not reflect the views or opinions of the editorial staff.

Credit: Teva. The generic product is supplied in a prefilled, single-patient-use pen. Teva has launched an authorized generic version of Victoza ® (liraglutide injection). Liraglutide is a ...

Novo Nordisk's Victoza, a popular diabetes medication, has shown mixed results in a mid-stage trial targeting Alzheimer's disease. While the drug failed to meet its primary endpoint of improving brain ...

Novo Nordisk's (NVO) new type-2 diabetes drug Victoza is rapidly gaining market share in the all-important U.S. market. The Danish drug maker's early commercial success with its subcutaneous "GLP-1" ...

With one drugmaker already trying to pry patent protection off of Novo Nordisk’s blockbuster Victoza before its 2022 expiration, the insulin specialist has taken new steps to deter copies. The Danish ...

Two products for the treatment of type 2 diabetes, insulin degludec (Tresiba) and liraglutide (Victoza), both from Danish drug firm Novo Nordisk, have this week been given positive opinions for ...